Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Trk-IN-6

Trk-IN-6 shows excellent in vitro potency on a panel of TRK mutants (IC50 = 0.2-0.7 nM) .

Product Specifications

CAS Number

[2489327-43-5]

UNSPSC

12352005

Target

Trk Receptor

Type

Reference compound

Related Pathways

Neuronal Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/trk-in-6.html

Solubility

10 mM in DMSO

Smiles

FC1=CC=C(OCC(F)F)C([C@@H](C)NC2=NC3=C(C4=CN(CCO)N=C4)C=NN3C=C2)=C1

Molecular Formula

C21H21F3N6O2

Molecular Weight

446.43

References & Citations

[1]Zhuo LS, et al. Discovery of Next-Generation Tropomyosin Receptor Kinase Inhibitors for Combating Multiple Resistance Associated with Protein Mutation. J Med Chem. 2021 Oct 28;64 (20) :15503-15514.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TMIE, ID (TMIE, Transmembrane inner ear expressed protein) (Azide free) (HRP) discontinued
043031-HRP 200 µL

TMIE, ID (TMIE, Transmembrane inner ear expressed protein) (Azide free) (HRP) discontinued

Ask
View Details
VEGFC (NM_005429) Human Recombinant Protein
TP720451XL 1 mg

VEGFC (NM_005429) Human Recombinant Protein

Ask
View Details
Pinatuzumab (Anti-Siglec-2 / CD22)
C00777-01 1 mg

Pinatuzumab (Anti-Siglec-2 / CD22)

Ask
View Details
Pinatuzumab (Anti-Siglec-2 / CD22)
C00777-02 5x 1 mg

Pinatuzumab (Anti-Siglec-2 / CD22)

Ask
View Details
Pinatuzumab (Anti-Siglec-2 / CD22)
C00777-03 25x 1 mg

Pinatuzumab (Anti-Siglec-2 / CD22)

Ask
View Details
Graphislactone A
G065-5MG 5 mg

Graphislactone A

Ask
View Details